Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ViiV Healthcare
ViiV Healthcare
ViiV’s Triumeq to end Gilead’s monopoly in HIV
Pharmaphorum
Wed, 09/10/14 - 11:33 am
ViiV Healthcare
Gilead Sciences
HIV
Triumeq
Glaxo Seeks EU Approval for HIV Drug
Yahoo/Zacks
Tue, 10/29/13 - 10:44 am
GSK
Europe
HIV
Tivicay
ViiV Healthcare
abacavir
lamivudine
ViiV Healthcare files new drug application for three-drug HIV pill with US FDA
Pharmaceutical-Technology
Wed, 10/23/13 - 09:57 am
HIV
FDA
ViiV Healthcare
Dolutegravir
abacavir
lamivudine
ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1
Yahoo
Fri, 09/13/13 - 08:30 am
Dolutegravir
ViiV Healthcare
Darunavir
HIV-1
ING114915
Can This HIV Drug Challenge Gilead's Domination?
Motley Fool
Wed, 08/28/13 - 08:48 am
Gilead
HIV
ViiV Healthcare
Tivicay
GSK
Shionogi
Pfizer
FDA Delivers a Double Dose of Good News in the Fight Against HIV
Motley Fool
Wed, 08/14/13 - 09:15 am
FDA
HIV
Alere
Alere Determine
Tivicay
vaccines
ViiV Healthcare
GSK
Shionogi
Pfizer
Glaxo Wins U.S. FDA Approval for New Daily HIV Therapy
Bloomberg
Mon, 08/12/13 - 05:26 pm
GSK
FDA
HIV
ViiV Healthcare
Tivicay
Dolutegravir
ViiV Healthcare Partnership Anticipates New HIV Treatment Approval
Seeking Alpha
Sat, 06/22/13 - 10:09 am
ViiV Healthcare
GSK
Pfizer
Shionogi
Dolutegravir
HIV
Glaxo’s, Pfizer’s ViiV Licenses HIV Drug for Kids to Patent Pool
Bloomberg
Wed, 02/27/13 - 11:22 am
GSK
Pfizer
ViiV Healthcare
HIV
abacavir
GSK wins priority status for new HIV drug in U.S.
Reuters
Fri, 02/15/13 - 11:23 am
GSK
HIV
Shionogi
ViiV Healthcare
Dolutegravir
Glaxo Says No Plan for Viiv Spinoff ‘at the Moment’
Bloomberg
Thu, 01/10/13 - 09:04 am
GSK
ViiV Healthcare
Shionogi applies for HIV drug approval in U.S., Europe
Reuters
Tue, 12/18/12 - 11:14 am
Shionogi
HIV
FDA
Europe
Dolutegravir
ViiV Healthcare
Can These 3 Companies Take Down Gilead?
Motley Fool
Thu, 07/12/12 - 11:27 am
Gilead
HIV
ViiV Healthcare
Shionogi
Merck
Bristol-Myers Squibb
Glaxo Is ‘Happy’ With Human Genome Relationship, Viiv Venture
Bloomberg
Tue, 01/10/12 - 09:31 am
GSK
Human Genome Sciences
ViiV Healthcare
HIV
Pfizer
Glaxo-Pfizer AIDS Pill May Dislodge Bristol’s, Study Suggests
Bloomberg
Tue, 07/19/11 - 12:22 pm
AIDS
HIV
GSK
Pfizer
Bristol-Myers Squibb
Dolutegravir
Sustiva
ViiV Healthcare
Report: GSK has no plans to sell HIV unit
Fierce Biotech
Fri, 05/6/11 - 10:04 am
HIV
M&A
GSK
ViiV Healthcare
Pfizer
Some Drugmakers Hold Talks With The Patent Pool
Pharmalot
Fri, 02/11/11 - 12:09 pm
patents
HIV
Gilead Sciences
Sequoia
ViiV Healthcare
GSK
Pfizer
Medicines Patent Pool
Idenix Falls as FDA Places Hold on HIV Drug, Releases Another
Bloomberg
Thu, 02/10/11 - 10:00 am
Idenix
FDA
HIV
GSK
ViiV Healthcare
GlaxoSmithKline Launches Specialist HIV Company
Smart Money
Tue, 11/3/09 - 09:18 am
GSK
HIV
ViiV Healthcare
Pages
« first
‹ previous
1
2
3
4